Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 19Lung Neoplasms 18Breast Neoplasms 12Multiple Myeloma 10Carcinoma, Non-Small-Cell Lung 9Leukemia, Myeloid, Acute 8Rectal Neoplasms 7Carcinoma, Hepatocellular 7Myelodysplastic Syndromes 6Mouth Neoplasms 6Sarcoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Oropharyngeal Neoplasms 5Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Head and Neck Neoplasms 5Brain Neoplasms 5Ovarian Neoplasms 4Melanoma 4Lymphoma, B-Cell 4Leukemia, Biphenotypic, Acute 4Glioma 4Fallopian Tube Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Laryngeal Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 2High-Energy Shock Waves 2perflutren 1exemestane 1abemaciclib 1X-Rays 1Tamoxifen 1Specimen Handling 1Letrozole 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Fluorodeoxyglucose F18 1Estradiol 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage III Breast Cancer AJCC v8 × X-Rays × Clear all
NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡